EUVIMEDEUVIMED entdecken
Crossref

Effects of ADIPOQ and NOS3 SNPs/haplotypes on Blood Pressure Control in Patients With Adherence to Antihypertensive Therapy

Warlley R Cunha iD, Lívia C Agostini, Wellington Ms Dos Moreira, Luiz Fernando M Teixeira, Wendel C Vital, Glenda N da Silva, Nayara Nt Silva, Marcelo R Luizon iD, Gustavo H Oliveira-Paula, Angélica A Lima, Vanessa A Belo iD

Pharmacogenomics · 2023-04 · 24 (5) · 269-281

DOI: 10.2217/pgs-2023-0012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacogenomics, online erschienen am 04.04.2023. Verfasst von Warlley R Cunha und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, School of Pharmacy, Federal University of Ouro Preto, CEP, 35400-000, Ouro Preto, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Antihypertensive Agents, Hypertension. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Municipal Health Department of Ouro Preto.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim: We examined whether ADIPOQ (rs266729 and rs1501299) and NOS3 (rs3918226 and rs1799983) SNPs or the haplotypes formed by them, affect blood pressure (BP) control in 196 patients with adherence to antihypertensive therapy grouped into controlled (BP

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antihypertensive AgentsHypertensionHumansBlood PressurePolymorphism, Single NucleotideHaplotypesAdiponectinNitric Oxide Synthase Type III

Stichwörter der Autor:innen

ADIPOQNOS3adiponectinantihypertensivehaplotypeshypertensionmedication adherencenitric oxidepharmacogeneticspolymorphims

Substanzen

Antihypertensive AgentsAdiponectinNOS3 protein, humanNitric Oxide Synthase Type IIIADIPOQ protein, human

Autor:innen und Institutionen

  • Department of Pharmacy, School of Pharmacy, Federal University of Ouro Preto, CEP, 35400-000, Ouro Preto, Minas Gerais, Brazil.
  • Department of Clinical Analysis, School of Pharmacy, Federal University of Ouro Preto, CEP, 35400-000, Ouro Preto, Minas Gerais, Brazil.
  • Department of Genetics, Ecology & Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, CEP, 31270-901, Belo Horizonte, MG, Brazil.
  • Division of Cardiology, Department of Medicine, Wilf Family Cardiovascular Research Institute, Albert Einstein College of Medicine, New York, NY, USA.

ORCID-Profile: Warlley R Cunha, Marcelo R Luizon, Vanessa A Belo

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Municipal Health Department of Ouro Preto
  • Federal University of Ouro Preto

Zitieren

APA

Cunha, W. R., Agostini, L. C., Dos Moreira, W. M., M Teixeira, L. F., Vital, W. C., da Silva, G. N., Silva, N. N., Luizon, M. R., Oliveira-Paula, G. H., Lima, A. A., & Belo, V. A. (2023). Effects of ADIPOQ and NOS3 SNPs/haplotypes on Blood Pressure Control in Patients With Adherence to Antihypertensive Therapy. Pharmacogenomics, 24(5), 269-281. https://doi.org/10.2217/pgs-2023-0012

Vancouver

Cunha WR, Agostini LC, Dos Moreira WM, M Teixeira LF, Vital WC, da Silva GN, et al. Effects of ADIPOQ and NOS3 SNPs/haplotypes on Blood Pressure Control in Patients With Adherence to Antihypertensive Therapy. Pharmacogenomics. 2023;24(5):269-281. doi:10.2217/pgs-2023-0012

BibTeX
@article{Cunha2023,
  author = {Cunha, Warlley R and Agostini, Lívia C and Dos Moreira, Wellington Ms and M Teixeira, Luiz Fernando and Vital, Wendel C and da Silva, Glenda N and Silva, Nayara Nt and Luizon, Marcelo R and Oliveira-Paula, Gustavo H and Lima, Angélica A and Belo, Vanessa A},
  title = {Effects of ADIPOQ and NOS3 SNPs/haplotypes on Blood Pressure Control in Patients With Adherence to Antihypertensive Therapy},
  journal = {Pharmacogenomics},
  year = {2023},
  volume = {24},
  number = {5},
  pages = {269--281},
  doi = {10.2217/pgs-2023-0012}
}
Kostenlos starten →